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ABSTRACT
 نع  فشكلل  لوطلا/رصلخا  ةبسن  عافترلا  يصيخشتلا  ءادلأا  مييقت  :فادهلأا
 ينيدوعسلا ينغلابلا ينب ضيلاا ةمزلاتمو ةيئاعولا ةيبلقلا رطلخا لماوع
 نم  اًغلاب  اًيدوعس  3063  تلمش  يتلا  ةيعطقلما  ةساردلا  هذه  تيرجأ  :ةيجهنلما
 )م2014-م2013( نم ةرتفلا للاخ ضايرلاب دلاخ كللما ىفشتسبم ينسنلجا لاك
 ةيويحو ةيئايميك تاسايقو تانايبتسا ءارجا نمضتت ةلسلستم تاوطخ للاخ نم
 ةمزلاتمو  ةيزكرلما  ةنمسلا  ديدتح  يف  لوطلا/رصلخا  ةبسن  مييقت  تم  .ينكراشملل
 ىنحنلما تتح ةقطنلما باسحو يقلتلما ليغشتلا صئاصخ ىنحنم مادختساب ضيلأا
 تلايلتح  قيبطت  تم  .ةيبلسلاو  ةيباجيلإا  ةيؤبنتلا  ميقلاو  ةيعونلاو  ةيساسلحاو
 بسن باسلح سنلجاو رمعلا بسح ةلدعلما تاريغتلما ددعتم يتسجوللا رادحنلاا
 .ةلدعلما ةيحجرلأا
 0.5نع لوطلا/رصلخا ةبسن عافترا نأ ىنحنلما تتح ةقطنلما ميق ترهظأ :جئاتنلا
 ةمزلاتمو ،)0.98 ىنحنلما تتح ةقطنم( ةيزكرلما ةنمسلا صيخشتل ةزاتمم ةردق اهل
 ينلماع  نم  رثكأ  دوجو  صيخشت  ىلع  ةرداق  تناك  كلذك  ؛)0.86(  ضيلاا
 ىتح ًايضرم يصيخشتلا ءادلاا ناكو )0.79( ةيئاعولاو ةيبلقلا ضارملال ةروطخ
 ةيؤبنتلا ميقلاو ةيساسلحا تزواتج .)0.66( مدلا يف نوهدلا للخ صيخشت يف
 .مدلا  طغض عافتراو  يركسلا  ضرمو ةيزكرلما  ةنمسلا  صيخشتل  85%  ةيبلسلا
 لكشب داز 0.5 نع لوطلا/رصلخا ةبسن ةدايز نأ يتسيجوللا رادحنلاا ليلتح تبثأ
 اًبيرقت  فاعضأ ةعبرأ  وحنب  مدلا  طغض عافتراو يركسلاب  ةباصلإا رطخ نم ريبك
 . مدلا يف نوهدلا للخب ةباصلإا ةروطخ تفعاضت كلذكو
 يصيخشت ءادأ هل لوطلا ىلارصلخا طيحم ةبسن عافترانا ةساردلا ترهظأ :ةصلالخا
 ينب  ةيئاعولاو  ةيبلقلا  ضارملال  ةروطلخا  لماوع  كلذكو  ضيلاا  ةمزلاتلم  ديج
 يركسلاب ةباصلإا رطخ نم داز دق 0.5 نع ةبسنلا ةذه عافترا نا امك .ينيدوعسلا
نوهدلا للخ كلذكو مدلا طغض عافتراو
Objectives: To evaluate the diagnostic performance of 
waist to height ratio (WHtR) to screen for cardiovascular 
risk factors (CVRF) and metabolic syndrome (MetS) 
among Saudis.
Methods: Between June 2013 and August 2014, a cross-
sectional study of 3,063 adult Saudis of both genders 
from King Khalid Hospital, Riyadh, Saudi Arabia was 
conducted. Using the “WHO STEPwise Surveillance-
Instrument V2.1”, which uses sequential  steps including 
questionnaires and anthropometric and biochemical 
measurements of MetS and CVRF.  Waist to height ratio 
Original Article
validity in defining central obesity, MetS, and CVRF 
were tested using receiver operating characteristic curve 
(ROC), sensitivity, specificity, positive and negative 
predictive values, and accuracy. Using multivariate 
regression analyses for adjustment of confounders as age 
and gender were applied to compute adjusted odds ratios 
(aOR). 
Results: The diagnostic potential of WHtR was excellent 
for central obesity (area under the curve [AUC] = 0.98), 
and MetS (AUCs = 0.86); it was good for CVRF ≥2 
(AUCs = 0.79) and was satisfactory for dyslipidemia 
(AUCs = 0.66). The sensitivities and negative predictive 
values exceeded 85% for diagnosing central obesity, 
diabetes, and hypertension. Adjusted odds ratios  for 
age and gender showed that WHtR ≥0.50 significantly 
increased the risk of diabetes, hypertension, and ≥2 
CVRF by almost 4-fold, and increased the risk of 
dyslipidemia by 2-fold.
Conclusion: Waist height ratio showed a good 
diagnostic performance for CVRF and MetS among 
Saudis. Furthermore, WHtR ≥0.5 increased the risk of 
dyslipidemia, diabetes mellitus and  hypertension. 
Keywords: waist to height ratio, metabolic syndrome, 
cardiovascular risk, Saudi Arabia
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Central obesity has been recognized as a significant risk factor of cardiovascular diseases (CVD); it is 
substantially associated with individual cardiovascular 
risk factors (CVRF), as hypertension, dyslipidemia, and 
diabetes.1 The pathogenesis of CVD is believed to be 
linked to central obesity and increase adiposity of the 
body through inducing insulin-resistance and other 
inflammatory mediators. This pathological effect of 
central obesity can induce these changes even among 
population with normal weight.2,3 Measurement 
of visceral obesity is best estimated by computed 
tomorgraphy (CT); however, although considered to 
be the “gold standard”, it requires exposure to ionizing 
radiation and is highly expensive. On the contrary, 
anthropometric proxies can be obtained simply and 
a growing evidence of their diagnostic performance 
encouraged clinicians to use them to avoid exposing 
their patients to CT hazards.4 
Analyses to verify the performance of each 
anthropometric index as a CVD risks screening tool 
in adults showed that waist-to-height ratio (WHtR) 
is  consistently better than waist circumference 
(WC) or body mass index (BMI). In 2008, a meta-
analysis including 88,000 participants from different 
populations supported the evidence that WHtR is a 
promising tool in discriminating CVD risks related to 
central obesity.5 This evidence was ascertained in 2012 
by another meta-analysis that included 31 studies and 
involved 300,000 adults from different ethnic groups. 
Authors of this study applied a robust statistical analysis 
and further verified the value of WHtR to screen for 
CVD risks.3 In 2016, Ashwell et al6 concluded that the 
use of WHtR classifies people at ‘early health risk’ more 
effectively than using BMI and WC or even using a 
matrix of both BMI and WC. 
Waist-to-height ratio was originally proposed as 
an index of central obesity, with a boundary value of 
0.5 effectively discriminating obese and non-obese 
individuals. This value is globally accepted, as revealed 
in previous research from various population and in 
a meta-analysis. Hence, WHtR was considered as a 
simple and a low-cost primary screening tool to screen 
for health risks. Furthermore, the unified cutoff value of 
WHtR was globally translated to a simple slogan “keep 
your waist circumference to less than half your height”.7 
Metabolic syndrome (MetS) is a cluster of conditions 
that increases CVD risks; the dilemma of which index 
that best discriminates MetS has been verified in a 
large Chinese study that evaluated the anthropometric 
and atherogenic indices. The study concluded that in 
men, WHtR superseded all the indices as it has the 
greatest area under the curve (AUC), but in women, 
the triglycerides/high-density lipoprotein-c had the 
largest AUC of 0.815, whereas the AUC of WHtR was 
slightly attenuated (0.780). Nevertheless, the sensitivity 
of WHtR was the highest for both genders.8
In the recent decades, Saudi Arabia (SA) has 
witnessed drastic lifestyle changes towards unhealthy 
dietary habits and a sedentary lifestyle. This seemed to 
have driven the obesity epidemic in SA; currently SA has 
one of the most alarming prevalence of obesity in the 
world. Consequently, MetS, diabetes, and CVD have 
become major challenges faced by health authorities in 
the Kingdom.9
Despite the high prevalence of diabetes and other 
cardiometabolic risks among Saudis, studies in KSA 
that investigated various obesity indices and its relation 
to CVD risks are scarce, and they rarely reported the 
diagnostic performance of WHtR in cardiovascular or 
metabolic risks.10-12 
Therefore, this study aimed to explore the diagnostic 
performance of WHtR to predict MetS and various 
CVRF including central obesity, diabetes, hypertension, 
and dyslipidemia among adult Saudis.  
Methods. This cross-sectional study is a sub-cohort 
analysis from the Heart Health Promotion (HHP) 
Study conducted in Riyadh, the capital city of Saudi 
Arabia, during the period from 2013 to 2014, which 
included employees with some of their family members 
at King Saud University. The HHP study prospectively 
recruited 4,500 Saudi and non-Saudi participants.13 
This study reports results among 3,063 Saudi 
participants , including 1,907 (62%) women and 1,156 
(38%) men. Considering prevalence of obesity as of 
25% ± 5% (p<0.01), a power of >0.9 was calculated 
using STATA/IC14.2.
After approval from the Institutional Review Board 
(IRB) at King Saud University (reference number 
13-3721), the study was conducted according to the 
guidelines of Helsinki Declaration. Informed consent 
were signed from all participants. The cohort profile 
was published in 2016.13 We collected data using the 
Disclosure. Authors have no conflict of interests, and 
the work was not supported or funded by any drug 
company. This study was funded by the Deanship of 
Scientific Research at Princess Nourah bint Abdulrahman 
University, Riyadh, Saudi Arabia through the fast track 
research funding program
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“WHO STEPwise approach to chronic disease risk 
factor surveillance-instrument V2.1” the instrument 
uses serial steps which assess self-reported variable, 
anthropometric measurements , and biochemical 
measurements.14 
A flexible non-stretchable plastic tape was used to 
measure height and waist circumference (in centimeter). 
General obesity was considered if BMI ≥30 kg/m2,15 
while, central obesity was labeled if WC ≥102 cm in 
males and 88 cm in females.16
Participants were asked to fast for at least 12 hours 
before collecting blood samples. The biochemical 
measurements in this study included: glycosylated 
hemoglobin (HbA1c), high-density lipoprotein 
cholesterol (HDL-C), low-density lipoprotein 
cholesterol (LDL-C), total cholesterol (TC), and 
triglycerides (TGs).    
Hypertension was classified following the seventh 
report of the Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood 
Pressure (JNC7).16 However, participants were also 
deemed hypertensive if they self-reported current use 
of any antihypertensive medications irrespective of their 
blood pressure readings. 
Diabetes mellitus was defined in accordance with 
the World Health Organization (WHO) and American 
Diabetes Association criteria (HbA1c level was ≥6.5%), 
or by self-reporting of previous diagnosis of diabetes 
and use of antidiabetic medications.17
Participants were considered as having dyslipidemia 
according to the WHO and the Third Adult Treatment 
Panel (ATP-III) of the National Cholesterol Education 
Program (NCEP). Dyslipidemia was defined as high 
level of TC, LDL-C, or TGs, and low level of HDL-C. 
A subject was also considered as having dyslipidemia if 
using blood lipid lowering medication.18
Participants were identified as having metabolic 
syndrome (MetS), if they had at least 3 out of the 5 
factors described in  the NCEP-ATPIII criteria.18
Statistical analysis. We analyzed data using 
SPSS version 18.0 (SPSS Inc., Chicago, IL, USA). 
Quantitative variables were expressed as means and 
standard deviation (SD), whereas categorical variables 
were expressed as frequency and proportions. 
The validity of WHtR in defining obesity, central 
obesity, diabetes, hypertension, dyslipidemia, MetS, 
and cardiovascular risk factors (CVRF) ≥2 was tested 
using receiver operating characteristic curve (ROC). 
Statistical significance of the ROC curve was determined 
using an AUC. The performance of the WHtR to 
detect cardiovascular risk factors was assessed by 
computing AUC. Area under the curve  ≥0.9 indicates 
excellent discriminating power; AUCs of 0.8-0.89 and 
0.7-0.79 indicate very good and good discriminating 
powers, respectively; and AUC ≤0.5 indicates that the 
discriminatory power is unacceptable.
The positive predictive value (PPV), negative 
predictive value (NPV), and accuracy were calculated. 
Positive predictive value is the probability of a patient 
having the disease when the test is positive; NPV is the 
probability of a patient not having the disease when the 
test is negative; accuracy is the overall probability that 
the patient will be correctly classified.
Odds ratio and 95% confidence intervals (CI) were 
calculated by multivariate logistic regression analyses 
in models where different cardiovascular risks were 
considered as binary dependent outcomes and WHtR 
was considered an independent factor with adjustment 
for age and gender.
Results. This study included 3,063 Saudi employees 
and their families, the majority of whom were women 
(62%). The mean age of this cohort was 38.58 ±14.10 
years. The men were younger than the women, but 
showed significantly higher prevalence of dyslipidemia 
(70.4%) and CVRF ≥2 (61.6%) than women (53.2% 
and 52.9%, respectively). The prevalence of diabetes 
was comparable in both genders, with women showing 
higher likeliness to have general and central obesity. 
The other clinical characteristics and frequencies of 
cardiometabolic risk factors are shown in Table 1.
Receiver operating characteristic curves were 
constructed to measure the discriminative ability of 
WHtR to predict CVRF, such as diabetes, hypertension, 
dyslipidemia,  CVRF ≥2, and MetS (Figure 1). 
Table 2 compares WHtR performance with BMI 
and WC among the total study population and between 
genders. The AUC differed significantly from the AUC 
value of 0.5 (p<0.01) for all risk factors and in both 
genders. Among women, WHtR showed the strongest 
relationship with MetS (AUC 0.89, CI 0.87-0.91) 
and the weakest with dyslipidemia (AUC 0.64, 
CI 0.62-0.67). Likewise, among male participants, 
WHtR showed the highest discriminating ability in 
MetS (AUC 0.81, CI 0.78-0.84) and the lowest in 
dyslipidemia (AUC 0.66, CI 0.63-0.66).
Waist-to-height ratio  performance surpassed that of 
BMI in nearly all CVRF especially diabetes, prediabetes 
and MetS, whilst, it showed a comparable performance 
with WC even in defining MetS. Waist to height ratio 
showed very high agreement with WC in defining 
central obesity among males and females with AUC 
of 0.98 (0.97-0.98) reflecting its high discriminative 
power. 
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Age (years)   38.58 ± 14.10   37.99 ± 14.34   38.95 ± 13.94 0.07
Weight (kg)   75.82 ± 18.02   82.66 ± 19.24   71.68 ± 15.87 <0.01
Height (cm) 163.09 ± 9.05 171.02 ± 7.09 158.28 ± 6.31 <0.01
BMI (kg/m2)   28.50 ± 6.26   28.20 ± 5.99   28.68 ± 6.41 0.04
WC (cm)   83.57 ± 14.83   90.20 ± 14.58   79.54 ± 13.47 <0.01
WHtR     0.51 ± 0.09     0.53 ± 0.09     0.50 ± 0.09 <0.01
SBP 118.05 ± 14.81 122.78 ± 13.05 115.18 ± 15.08 <0.01
DBP   70.14 ± 10.91   73.70 ± 12.78   67.99 ± 8.93 <0.01
TC (mmol/l)     4.90 ± 0.93     4.87 ± 0.97     4.92 ± 0.91 0.16
HDL (mmol/l)     1.30 ± 0.36     1.13 ± 0.29     1.40 ± 0.35 <0.01
LDL (mmol/l)     3.05 ± 0.83     3.11 ± 0.89     3.02 ± 0.80 <0.01
TAG (mmol/l)     1.22 ± 0.86     1.42 ± 1.08     1.09 ± 0.65 <0.01
Frequency of cardiometabolic risk factors among the studied population 
Obesity 1127 (36.8) 383 (33.1) 744 (39.0) <0.01
Central obesity 732 (23.9) 233 (20.2) 499 (26.2) <0.01
Diabetes 549 (17.9) 200 (17.3) 349 (18.3) 0.48
Prediabetics 759 (24.8) 307 (26.6) 452 (23.7) 0.22
Hypertension 613 (20.0) 252 (21.8) 361 (18.9) 0.05
Dyslipidemia 1828 (59.7) 814 (70.4) 1014 (53.2) <0.01
MetS 633 (20.7) 249 (21.5) 384 (20.1) 0.35
CVRF ≥2 1720 (56.2) 712 (61.6) 1008 (52.9) <0.01
Values are presented as mean ± standard deviation (SD), or number (%).
Participants were classified as having obesity if BMI ≥30 kg/m2 and having central obesity if WC ≥88 cm for 
women or ≥102 cm for men.  WC: waist circumference, WHtR: waist height ratio, TC: total cholesterol, 
HDL: high-density lipoprotein cholesterol, LDL: low-density lipoprotein cholesterol, TAG: triglycerides, 
MetS: metabolic syndrome, CVRF: cardiovascular risk factors 
Figure 1 confirms the superiority of WHtR 
compared to BMI and WC. Table 3 shows the diagnostic 
performance of WHtR ≥0.50 for CVRF and MetS. The 
sensitivity ranged from 0.72 to 0.99 among women 
and 0.59 to 0.91 among men. The specificity ranged 
between 0.42-0.55 for women and 0.58-0.75 for men. 
Additionally, all sensitivities and NPV exceeded 85% 
for diagnosing diabetes, MetS and hypertension that 
reflect the high ability to rule-out these risk factors 
when the result is negative.
Prediction of CVRF after adjusting for the 
confounder effects of age and gender was conducted 
using logistic regression models, using WHtR ≥0.50, 
BMI ≥30, and WC ≥88 cm for women or ≥102 cm 
for men. Waist to height ratio  ≥0.50 significantly 
increased the risk of having diabetes, hypertension, and 
CVRF ≥2 by nearly 4-fold, as well as increased the risk 
of developing dyslipidemia by 2-fold. The capability 
of WHtR to predict CVRF corresponded to BMI and 
WC abilities, as shown in Table 4.
Discussion. This study confirmed the strong 
diagnostic performance of WHtR in predicting CVRF 
including central obesity, diabetes, hypertension, 
dyslipidemia, and MetS among the adult Saudi 
population. The globally accepted cutoff value of 0.5 
possessed a good discriminating power among this 
group of Saudis who were at the age of increased risk 
of CVD. In the current study, WHtR was superior 
to BMI and WC in discriminating participants with 
different CVRF. Waist to height ratio  is considered 
one of the best indicators for CVRF not only because 
of its superiority to BMI and other indices such as 
WC but also owing to its inexpensive nature and 
great ease of use. Waist to height ratio  also allowed 
adjustment of WC by stature in both genders and in 
among various ethnic and age groups, resulting in little 
variations among various populations.19 Our findings 
showed that WHtR was able to discriminate diabetic 
patients from those with central obesity more precisely 
than BMI, as revealed by ROC curves and regression 
models. Waist to  height ratio is believed to correlate 
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Table 2 - Area under the curve (AUC) of WHtR, BMI, and WC in relation to different CVRF.







Diabetes 0.78 (0.76-0.80) 0.73 (0.70-0.77) 0.80 (0.78-0.83)
Prediabetes 0.71 (0.69-0.73) 0.68 (0.65-0.72) 0.73 (0.70-0.76)
Hypertension 0.79 (0.77-0.81) 0.73 (0.70-0.77) 0.82 (0.80-0.84)
Dyslipidemia 0.66 (0.64-0.68) 0.66    (0.63-70) 0.64 (0.62-0.67)
MetS 0.86 (0.85-0.88) 0.81 (0.78-0.84) 0.89 (0.87-0.91)
CVRF ≥ 2 0.79 (0.77-0.81) 0.78 (0.75-0.81) 0.79 (0.77-0.81)
Central obesity 0.98 (0.97-0.98) 0.98 (0.97-0.99) 0.99 (0.98-0.99)
BMI
Diabetes 0.69 (0.67-0.80) 0.63 (0.59-0.67) 0.73 (0.70-0.75)
Prediabetes 0.68 (0.66-0.70) 0.65 (0.62-0.69) 0.70 (0.67-0.73)
Hypertension 0.72 (0.70-0.74) 0.66 (0.63-0.70) 0.76 (0.73-0.78)
Dyslipidemia 0.62 (0.60-0.64) 0.63 (0.60-0.67) 0.62 (0.60-0.65)
MetS 0.79 (0.77-0.81) 0.75 (0.71-0.78) 0.81 (0.79-0.84)
CVRF ≥ 2 0.78 (0.76-0.80) 0.77 (0.74-0.80) 0.79 (0.77-0.81)
WC
Diabetes 0.75 (0.73-0.77) 0.72 (0.68-0.75) 0.79 (0.77-0.82)
Prediabetes 0.70 (0.68-0.72) 0.69 (0.65-0.72) 0.72 (0.69-0.75)
Hypertension 0.77 (0.75-0.79) 0.73 (0.69-0.76) 0.81 (0.78-0.83)
Dyslipidemia 0.67 (0.65-0.69) 0.65 (0.63-0.70) 0.64 (0.62-0.67)
MetS 0.84 (0.82-0.86) 0.81 (0.78-0.84) 0.88 (0.87-0.90)
CVRF ≥ 2 0.78 (0.77-0.81) 0.77 (0.74-0.80) 0.78 (0.76-0.80)
WHtR: waist to height ratio, BMI: body mass index, WC: waist circumference, MetS: metabolic syndrome, 
CVRF: cardiovascular risk factors
Figure 1 - Performance of different anthropometric indices in identifying A) hypertension, B) diabetes mellitus, C) MetS, D) dislipidemia, and E) CVRF ≥2. 
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Table 3 - Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of waist to height 
ratio (WHtR) for CVRF.
Variables Sensitivity Specificity PPV NPV Accuracy 
Diabetes 
Total 0.89 (0.89-0.91) 0.52 (0.50-0.54) 0.29 (0.27-0.31) 0.95 (0.95-0.96) 0.57
Females 0.89 (0.84-0.93) 0.42 (0.39-0.46) 0.24 (0.21-0.28) 0.95 (0.92-0.97) 0.50
Males 0.88 (0.85-0.91) 0.58 (0.56-0.61) 0.32    (0.29-35) 0.96 (0.94-0.97) 0.63
Prediabetes 
Total 0.72 (0.69-0.75) 0.60 (0.57-0.62) 0.42 (0.40-0.43) 0.84 (0.82-0.86) 0.63
Females 0.68 (0.64-0.73) 0.66 (0.63-0.68) 0.43 (0.41-0.46) 0.85 (0.82-0.86) 0.67
Males 0.78 (0.72-0.82) 0.49 (0.45-0.53) 0.40 (0.38-0.42) 0.83 (0.79-0.86) 0.58
Hypertension 
Total 0.88 (0.85-0.90) 0.53 (0.51-0.55) 0.32 (0.30-0.34) 0.95 (0.93-0.96) 0.60
Females 0.87 (0.82-0.90) 0.43 (0.40-0.47) 0.30 (0.27-0.33) 0.92 (0.89-0.94) 0.53
Males 0.89 (0.85-0.92) 0.59 (0.57-0.61) 0.33 (0.30-0.36) 0.97 (0.94-0.97) 0.64
Dyslipidemia 
Total 0.65 (0.62-0.67) 0.59 (0.56-0.62) 0.70 (0.68-0.72) 0.53 (0.50-0.56) 0.62
Females 0.72 (0.68-0.75) 0.57 (0.52-0.62) 0.80 (0.77-0.83) 0.46 (0.41-0.51) 0.67
Males 0.59 (0.56-0.62) 0.5 (0.56-0.63) 0.62 (0.59-0.63) 0.56 (0.53-0.59) 0.59
MetS
Total 0.94 (0.92-0.96) 0.55 (0.53-0.57) 0.35 (0.34-0.36) 0.97 (0.96-0.98) 0.63
Females 0.95 (0.92-0.97) 0.61 (0.53-0.63) 0.38 (0.36-0.40) 0.98 (0.97-0.99) 0.68
Males 0.92 (0.88-0.95) 0.45 (0.47-0.48) 0.32 (0.30-0.33) 0.96 (0.93-0.97) 0.55
≥2 CVRF
Total 0.75 (0.73-0.77) 0.70 (0.67-0.73) 0.76 (0.75-0.78) 0.68 (0.66-0.70) 0.73 
Females 0.74 (0.71-0.77) 0.67 (0.66-0.72) 0.71 (0.68-0.73) 0.72 (0.70-0.74) 0.71
Males 0.80 (0.77-0.83) 0.65 (0.60-0.69) 0.78 (0.76-0.81) 0.67 (0.64-0.71) 0.74
MetS: metabolic syndrome, CVRF: cardiovascular risk factors
Table 4 - Adjusted odds ratios for cardiovascular risk factors adjusted for age and gender according to WHtR, BMI, 
and WC.
Risk factor WHtR BMI WC
Hypertension 3.68   (2.80-4.85) 2.86 (2.31-3.53) 3.62      (2.91-4.49)
Diabetes 3.84   (2.86-5.16) 1.84 (1.49-2.28) 3.22      (2.58-4.02)
Dyslipidemia 1.84   (1.56-2.17) 1.43 (1.22-1.69) 1.35     (1.12-1.63)
MetS 10.8  (7.73-15.37) 5.00 (4.06-6.16) 13.18 (10.51-16.52)
≥2 CVRF   3.79  (3.18-4.51) 3.10 (2.59-3.72) 2.75     (2.21-3.41)
Values are presented as OR (95% CI); MetS: metabolic syndrome, CVRF: cardiovascular risk 
factors, OR: odds ratio and 95 % confidence intervals. Waist height ratio (WHtR) ≥0.5; body mass index (BMI) 
≥30; waist circumference (WC) ≥88 cm for women, ≥102 cm for men.
strongly with central obesity and, consequently, with 
visceral fat, which produces diabetogenic substances, 
and with insulin resistance, which correlates with type 
2 diabetes and impaired glucose tolerance. Additionally, 
WHtR was proved superior to BMI in predicting 
adiposity and central fat distribution in many studies 
of different ethnic backgrounds.20,21 In a large Chinese 
survey,22 the association of WHtR with undiagnosed 
patients with type 2 diabetes and even in prediabetics 
was stronger than that of BMI and WC in males, while 
the associations of WHtR and WC were stronger than 
those of BMI in females. The researchers added that 
WHtR ratio had the greatest AUCs in men and women. 
These findings support the current results and extended 
the effectiveness of WHtR to predict prediabetic 
conditions that are mostly undiagnosed and ignored. 
Many studies have tried to correlate different obesity 
indices with hypertension. In the current study, WHtR 
was more powerful than BMI in defining hypertensive 
patients. This finding agrees with those of many 
studies from Jordan,23 Nigeria,24  Iran,25  and China.26  
Moreover, WHtR discriminates both hypertensive and 
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hypotensive individuals of both genders in a Korean 
study.27 Diagnosis of dyslipidemia requires evaluation of 
HDL-C, TGs, and LDL-C, which is considered costly 
and unaffordable for screening a considerable number of 
healthy individuals. In this study, WHtR was satisfactory 
in discriminating patients with dyslipidemia, especially 
among women.28 These findings agree with other studies 
that recommended WHtR as an inexpensive tool for 
predicting dyslipidemia.29,30 Nevertheless, lipid profile 
may be high even in slim people; thus, caution should 
be paid not to rule out screening for dyslipidemia. 
Waist to height ratio  has recently been regarded as a 
novel screening tool to predict cardiometabolic risk 
factors and Mets. In this study, WHtR showed excellent 
discrimination of MetS (AUC = 0.86, CI = 0.85-0.88) 
and appreciable sensitivity and NPV that support the 
growing evidence of the advantageous use of WHtR for 
MetS screening. The ability of WHtR to predict MetS 
was intensively studied in cross-sectional and cohort 
studies; however, recently a prospective study among 
Spanish workers that examined the incidence of MetS 
over an approximately 9 years, added to the value of these 
studies and extended the usability of WHtR to other 
screening settings as occupational nursing clinics.19 The 
current study showed that the risk of having 2 or more 
CVRF among those whose WHtR exceeded 0.5 was 
nearly 4-times higher than that among those with lower 
WHtR. This finding showed the strong predictive power 
of WHtR in predicting single and multiple risk factors 
even after adjustment for age and gender. In 2017, a 
cross-sectional study of more than 26,000 middle-aged 
Chinese men tested the correlation between WHtR 
and WC with different indicators of cardiac health.29 
The researchers concluded that cardiovascular health 
score correlated strongly with WHtR, even stronger 
than with WC, and recommended the use of WHtR 
to screen populations at elevated risk for central obesity 
and CVDs. Additionally, a prospective cohort study in 
Germany that included 6670 males and 6637 females 
showed that WHtR appears to be a valid as risk predictor 
for CVD mortality in males but not females.31
Study limitations. One limitation of the current study 
was the cross-sectional design, that is known for several 
drawbacks. The other limitation was the non-random 
selection. In addition, as participants are employees 
and family members of one of the largest organizations 
in Saudi Arabia rather than representatives of the 
general population, the findings cannot be generalized 
to the entire population. Nevertheless, the completed 
documentations of all participants, along with the 
large sample size and their diverse socioeconomic 
backgrounds, could attenuate these limitations.
In conclusion, WHtR showed a good diagnostic 
performance in discriminating MetS and single and 
multiple CVRF, including central obesity, diabetes, 
hypertension, and dyslipidemia, among adult Saudis. 
The globally accepted cutoff point of 0.5, which can be 
easily applied for both genders, worked perfectly among 
Saudi women and men. Considering its non-invasive, 
ease of measurement, and low-cost methodology, we 
highly recommend WHtR as a tool for population-
based screening for the prevention and management of 
CVRF. 
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